Selective review of key perioperative renal-electrolyte disturbances in chronic renal failure patients

Chest

Volumn 115, Issue 5 SUPPL., 1999, Pages 149S-157S

  Yee, Jerry ^b   Parasuraman, Raviprasenna ^b   Narins, Robert G ^a  

^a Division of Hypertension and Nephrology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; ARGIPRESSIN; ATENOLOL; BICARBONATE; CALCIUM; CLONIDINE; DECONGESTIVE AGENT; DIURETIC AGENT; ELECTROLYTE; ENALAPRILAT; ESMOLOL; GLUCOSE; INSULIN; LABETALOL; METHYLDOPA; NICARDIPINE; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; PROPRANOLOL; SALBUTAMOL; SODIUM; WATER;

ANXIETY; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; EDEMA; ELECTROLYTE DISTURBANCE; FLUID BALANCE; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERKALEMIA; HYPERNATREMIA; HYPERTENSION; HYPONATREMIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SODIUM BALANCE;

EID: 0032936781     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.suppl_2.149S     Document Type: Conference Paper

References (40)

1. Schrier R. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med 1990; 113:155-159
2. Buckalew V Jr, Berg R, Wang S, et al. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Am J Kidney Dis 1996; 28:811-821
3. Parfrey P, Harnett J, Griffiths S, et al. Congestive heart failure in dialysis patients. Arch Intern Med 1988; 148:1519-1525
4. Venkatesan J, Henrich W. Anemia, hypertension, and myocardial dysfunction in end-stage renal disease. Semin Nephrol 1997; 17:257-269
5. Earley L, Daugharty T. Sodium metabolism. N Engl J Med 1969; 281:72-86
6. Tasker PR, MacGregor GA, De Wardener HE. Prophylactic use of intravenous saline in patients with chronic renal failure undergoing major surgery. Lancet 1974; 2:911-912
7. Kokot F, Wiecek A. Endocrine changes in chronic dialysis patients. In: Maher J, ed. Replacement of renal function by dialysis. 3rd ed. Boston, MA: Kluwer, 1989; 953-971
8. Brater D. Use of diuretics in chronic renal insufficiency and nephrotic syndrome. Semin Nephrol 1988; 8:333-341
9. Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med 1986; 81:1033-1041
10. Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine 1993; 72:359-373
11. Ayus J, Krothpalli R, Arieff A. Treatment of symptomatic hyponatremia and its relation to brain damage. N Engl J Med 1987; 317:1190-1195
12. Verbalis J, Martinez A. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int 1991; 39:1274-1282
13. Paice B, Gray JM, McBride D, et al. Hyperkalemia in patients in hospital. BMJ 1983; 286:1189-1192
14. Spencer R. Potassium metabolism and gastrointestinal function: a review. Am J Dig Dis 1959; 4:145-150
15. Battle DC, Arruda JA, Kurtzmann NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med 1981; 304:373-380
16. Perrone R, Alexander E. Regulation of extrarenal potassium metabolism. In: Narins RG, ed. Maxwell and Kleeman's clinical disorders of fluid and electrolyte metabolism. 5th ed. New York, NY: McGraw-Hill, 1993; 137-138
17. Martin R, Panese S, Virginillo M, et al. Increased secretion of potassium in the rectum of humans with chronic renal failure. Am J Kidney Dis 1986; 8:105-110
18. - exchange by insulin in the human forearm. Am J Physiol 1988; 255:953-958
19. Allon M, Takeshian A, Shanklin N. Effect of insulin-plusglucose infusion with or without epinephrine on fasting hyperkalemia. Kidney Int 1993; 43:212-217
20. Blumberg A, Weidmann P, Shaw S, et al. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988; 85:507-512
21. Riley LJ, Cooper M, Narins RG. Alkali therapy of diabetic ketoacidosis: biochemical, physiological and clinical perspective. Diabetes Metab Rev 1989; 5:627-636
22. Nicolis G, Kahn T, Sanchez A, et al. Glucose-induced hyperkalemia in diabetic subjects. Arch Intern Med 1981; 141: 49-53
23. Brown M, Whitworth J. Hypertension in human renal disease. J Hypertens 1992; 10:701-712
24. Estafanous F, Tarazi R. Systemic arterial hypertension associated with cardiac surgery. Am J Cardiol 1980; 46:685-694
25. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? a meta-analysis. Arch Intern Med 1994; 121:289-300
26. Prys-Roberts C, Meloche R, Foëx P. Studies of anaesthesia in relation to hypertension: I. Cardiovascular responses of treated and untreated patients. Br J Anaesth 1971; 43: 122-137
27. Kaufman R, Walts L. Tourniquet-induced hypertension. Br J Anaesth 1982; 54:333-336
28. Leslie J. Incidence and aetiology of perioperative hypertension. Acta Anaesthesiol Scand 1993; 37:5-9
29. Lloyd-Mostyn R, Oram S. Modification by propranolol of cardiovascular effects of induced hypoglycemia. Lancet 1975; 1:1213-1215
30. Ellis J, Drijver G, Pedlow S, et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesth Analg 1994; 79:1133-1140
31. Metz S, Klein C, Morton N. Rebound hypertension after discontinuation of transdermal clonidine therapy. Am J Med 1987; 82:17-19
32. Laslett L. Hypertension: preoperative assessment and perioperative management. West J Med 1995; 162:215-219
33. Palda V, Detsky A. Clinical guidelines: I. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med 1997; 127:309-312
34. Mangano D, Layug E, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery: multicenter study of perioperative ischemia research group. N Engl J Med 1996; 335:1713-1720
35. Zuccalá G, Pahor M, Landi F, et al. Use of calcium antagonists and need for perioperative transfusion in older patients with hip fracture: an observational study. BMJ 1997; 314:643-644
36. Orlowski J, Shiesley D, Vidt D, et al. Labetalol to control blood pressure after cerebrovascular surgery. Crit Care Med 1988; 16:765-768
37. Oxorn D, Knox J, Hill J. Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia. Can J Anaesth 1990; 37:206-209
38. Varriale P, David W, Chryssos B. Hemodynamic response to intravenous enalaprilat in patients with severe congestive heart failure and mitral regurgitation. Clin Cardiol 1993; 16:235-238
39. Neutal J, Smith D, Wallin D, et al. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hypertens 1994; 7:623-628
40. Calhoun D, Oparil S. Current concepts: treatment of hypertensive crisis. N Engl J Med 1990; 323:1177-1183